- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
BioLine Rx (NASDAQ:BLRX), Quotes and News Summary
BioLine Rx (NASDAQ: BLRX)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-17 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.150 | -0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
BioLine Rx Questions & Answers
You can purchase shares of BioLine Rx (NASDAQ: BLRX) through any online brokerage.
Other companies in BioLine Rx’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Orchard Therapeutics (NASDAQ:ORTX), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for BioLine Rx (NASDAQ: BLRX) was reported by HC Wainwright & Co. on Tuesday, February 23, 2021. The analyst firm set a price target for 19.00 expecting BLRX to rise to within 12 months (a possible 961.45% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BioLine Rx (NASDAQ: BLRX) is $1.79 last updated August 16, 2022, 8:00 PM UTC.
There are no upcoming dividends for BioLine Rx.
BioLine Rx’s Q3 earnings are confirmed for Thursday, November 17, 2022.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.